Michael Detke

Dr. Michael J.
Detke is a Chief Medical Officer at Lighthouse Pharmaceuticals, Inc. and a Professor at Indiana University.
Dr. Detke was previously employed as a Chief Medical Officer by Cortexyme, Inc., a Chief Medical Officer by Embera NeuroTherapeutics, Inc., a Chief Medical Officer by CoMentis, Inc., a President by Detke Biopharma Consulting LLC, a Head-Early Phase Development by CNS Therapeutics, Inc., an Executive Director by Eli Lilly & Co., an Executive Director by Lilly Research Laboratories, a Director & Chief Medical Officer by Medavante Research Institute, and a Chief Medical Officer by MedAvante, Inc. He received his undergraduate degree from Yale University, a graduate degree from Yale University, a graduate degree from the University of Pennsylvania and a doctorate degree from the University of Pennsylvania.